Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion.
Freeman, K Connock, M Cummins, E Gurung, T Taylor-Phillips, S Court, R Saunders, Mark P Clarke, A Sutcliffe, P
Freeman, K
Connock, M
Cummins, E
Gurung, T
Taylor-Phillips, S
Court, R
Saunders, Mark P
Clarke, A
Sutcliffe, P
Citations
Altmetric:
Abstract
5-Fluorouracil (5-FU) is a chemotherapy used in colorectal, head and neck (H&N) and other cancers. Dose adjustment is based on body surface area (BSA) but wide variations occur. Pharmacokinetic (PK) dosing is suggested to bring plasma levels into the therapeutic range to promote fewer side effects and better patient outcomes. We investigated the clinical effectiveness and cost-effectiveness of the My5-FU assay for PK dose adjustment to 5-FU therapy.
Description
Date
2015-11
Publisher
Collections
Keywords
Type
Article
Citation
Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion. 2015, 19 (91):1-322 Health Technol Assess